Alphatec Spine

Alphatec Spine (ATEC) stock price, revenue and financials

View Company

$130.2 M

ATEC Mkt cap, 15-Oct-2018

$43.3 M

Alphatec Spine Revenue Q2, 2018
Alphatec Spine Gross profit (Q2, 2018)27.8 M
Alphatec Spine Gross profit margin (Q2, 2018), %64.2%
Alphatec Spine Net income (Q2, 2018)-9 M
Alphatec Spine EBIT (Q2, 2018)-7.2 M
Alphatec Spine Cash, 30-Jun-201844.9 M
Alphatec Spine EV91.9 M

Alphatec Spine Revenue

Alphatec Spine revenue was $120.25 m in FY, 2016 which is a 35.1% year over year decrease from the previous period.

Embed Graph

Alphatec Spine Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

204.7m207.0m185.3m120.2m

Revenue growth, %

1%(10%)(35%)

Cost of goods sold

78.7m61.8m63.7m44.1m

Gross profit

126.1m145.1m121.5m76.1m

Gross profit Margin, %

62%70%66%63%

Sales and marketing expense

51.0m

R&D expense

9.2m

General and administrative expense

26.3m

Operating expense total

86.5m

EBIT

(73.4m)1.8m(172.4m)(15.4m)

EBIT margin, %

(36%)1%(93%)(13%)

Interest expense

4.0m13.6m12.6m5.4m

Interest income

6.0k10.0k53.0k3.0k

Pre tax profit

(178.0m)

Income tax expense

3.2m1.1m681.0k(4.6m)

Net Income

(82.2m)(12.9m)(178.7m)(29.9m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Revenue

50.2m49.2m53.2m51.0m48.6m46.6m43.0m44.8m43.8m26.7m28.0m24.4m21.3m43.3m

Cost of goods sold

25.5m15.4m16.6m14.3m15.3m18.7m14.2m13.5m15.5m10.8m11.2m8.6m7.7m15.5m

Gross profit

24.7m33.7m36.6m36.7m33.3m27.9m28.8m31.2m28.3m15.9m16.8m15.7m13.6m27.8m

Gross profit Margin, %

49%69%69%72%68%60%67%70%65%59%60%65%64%64%

Sales and marketing expense

18.1m18.1m19.8m18.6m18.2m16.6m17.1m19.1m18.1m11.8m11.1m10.3m10.1m20.7m

R&D expense

3.0m4.2m4.5m4.4m3.9m3.9m1.9m3.7m2.1m1.1m1.4m990.0k1.8m3.8m

General and administrative expense

11.4m14.2m9.2m10.2m9.1m9.2m8.1m10.6m8.3m4.1m6.2m5.4m6.4m14.3m

Operating expense total

37.4m38.0m34.3m34.6m31.8m30.4m193.4m34.6m29.1m20.4m20.2m16.5m14.2m35.1m

Depreciation and amortization

177.0k364.0k

EBIT

(13.2m)(4.7m)1.8m1.7m1.1m(2.8m)(164.9m)(3.7m)(1.2m)(4.5m)(3.4m)(735.0k)(667.0k)(7.2m)

EBIT margin, %

(26%)(10%)3%3%2%(6%)(384%)(8%)(3%)(17%)(12%)(3%)(3%)(17%)

Interest expense

1.0m1.7m3.7m3.9m3.4m3.0m3.1m3.4m3.7m1.1m2.0m1.9m1.7m3.4m

Interest income

2.0k3.0k3.0k2.0k7.0k12.0k18.0k20.0k16.0k

Pre tax profit

(2.3m)(10.6m)

Income tax expense

500.0k669.0k307.0k(28.0k)902.0k253.0k(1.7m)586.0k600.0k(5.0m)49.0k15.0k(458.0k)(1.7m)

Net Income

(14.5m)(6.7m)(2.9m)(3.0m)(4.6m)(3.9m)(160.3m)(6.6m)(5.2m)(13.7m)(5.5m)(2.7m)(1.9m)(9.0m)

Alphatec Spine Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

21.3m19.7m11.2m19.6m

Accounts Receivable

41.4m40.4m38.3m18.5m

Inventories

7.7m5.5m5.1m30.1m

Current Assets

113.7m113.1m101.9m72.8m

PP&E

28.0m26.0m21.9m15.1m

Goodwill

183.0m171.3m

Total Assets

365.6m344.9m146.7m94.2m

Accounts Payable

10.8m10.1m14.2m8.7m

Short-term debt

4.9m8.1m80.1m3.1m

Current Liabilities

79.7m63.6m125.4m40.1m

Long-term debt

Total Debt

3.1m

Additional Paid-in Capital

403.6m413.9m416.9m419.8m

Retained Earnings

(235.7m)(248.6m)(427.2m)(457.2m)

Debt to Assets Ratio

0 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Cash

18.7m23.8m19.0m20.2m11.4m8.9m10.5m7.8m9.3m25.6m25.5m19.1m47.6m44.9m

Accounts Receivable

41.7m38.8m44.7m40.1m38.9m38.9m36.3m39.4m36.5m16.5m14.2m13.1m12.0m11.4m

Inventories

43.1m42.5m42.4m42.0m41.8m41.2m42.3m48.0m44.1m27.7m30.1m29.8m28.9m28.2m

Current Assets

112.5m135.5m117.4m112.7m102.5m100.1m100.3m100.3m93.7m75.6m72.4m64.2m90.7m86.5m

PP&E

29.5m28.1m27.4m26.5m25.9m23.8m23.7m22.7m21.6m13.7m15.4m14.5m11.5m12.1m

Goodwill

181.4m183.1m182.3m175.1m161.7m163.8m14.3m14.3m

Total Assets

366.1m386.3m364.7m348.6m320.1m314.2m148.4m145.4m136.5m96.0m93.6m84.2m143.3m139.5m

Accounts Payable

14.2m16.5m14.0m11.3m8.9m10.4m10.8m19.3m17.4m6.8m4.2m2.9m3.8m3.4m

Short-term debt

5.0m4.2m5.9m8.0m7.3m6.8m59.0m78.1m75.4m2.6m2.6m2.3m6.9m6.7m

Current Liabilities

56.4m94.4m69.8m66.2m56.7m53.3m98.6m129.6m125.2m42.4m33.3m29.6m34.5m35.0m

Total Debt

5.0m4.2m5.9m8.0m7.3m6.8m59.0m78.1m75.4m2.6m2.6m2.3m6.9m6.7m

Additional Paid-in Capital

402.3m404.5m411.0m412.6m415.2m416.7m416.6m417.0m417.4m418.9m437.5m438.0m497.0m502.7m

Retained Earnings

(175.3m)(242.4m)(245.2m)(248.3m)(253.1m)(257.1m)(417.3m)(433.9m)(439.1m)(452.8m)(462.7m)(465.4m)(461.4m)(468.5m)

Total Equity

229.0m133.6m31.6m30.2m

Financial Leverage

1.6 x2.4 x4.5 x4.6 x

Alphatec Spine Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(82.2m)(12.9m)(178.7m)(29.9m)

Depreciation and Amortization

26.3m18.4m19.0m934.0k

Accounts Receivable

(1.9m)(1.0m)1.2m8.0m

Inventories

(4.4m)(4.3m)(5.5m)(5.7m)

Accounts Payable

(3.9m)(1.0m)3.2m(4.9m)

Cash From Operating Activities

7.8m(20.3m)10.1m(10.0m)

Purchases of PP&E

(14.4m)(11.3m)(12.2m)(8.9m)

Cash From Investing Activities

(19.1m)(11.0m)(12.2m)62.0m

Short-term Borrowings

(2.7m)(5.8m)(8.2m)(54.4m)

Cash From Financing Activities

10.7m30.7m(6.5m)(43.4m)

Interest Paid

4.0m5.9m7.6m7.4m

Income Taxes Paid

1.8m565.0k621.0k920.0k

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Net Income

(14.5m)(6.7m)(2.9m)(3.0m)(4.6m)(3.9m)(160.3m)(6.6m)(5.2m)(13.7m)(5.5m)(1.9m)(9.0m)

Depreciation and Amortization

172.0k1.9m3.5m

Accounts Receivable

44.7m40.1m38.9m38.9m36.3m39.4m36.5m16.5m14.2m2.8m3.3m

Inventories

(2.7m)(2.9m)

Accounts Payable

14.0m11.3m8.9m10.4m10.8m19.3m17.4m6.8m4.2m(192.0k)(620.0k)

Cash From Operating Activities

(5.3m)(8.7m)

Purchases of PP&E

(410.0k)(2.4m)

Cash From Investing Activities

(14.1m)(16.4m)

Cash From Financing Activities

44.6m47.5m

Interest Paid

1.1m2.3m

Income Taxes Paid

6.0k72.0k

Alphatec Spine Ratios

USDY, 2018

EV/EBIT

-12.7 x

EV/CFO

-10.6 x

Financial Leverage

4.6 x
Download Excel
Report incorrect company information
View Alphatec Spine profile

Competitors

SeaSpine
Healthcare - Public
MRI Interventions
Healthcare - Public
C. R. Bard
Healthcare - Public
Integra LifeSciences
Healthcare - Public
Compare competitors